![John Snisarenko](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Snisarenko
Président chez
ZENTEK LTD.
Fortune : 149 860 $ au 30/06/2026
Profil
Mr. John Snisarenko is an Independent Director at Cytophage Technologies Ltd. and a Non-Executive Chairman at Zentek Ltd. He is on the Board of Directors at Cytophage Technologies Ltd. Mr. Snisarenko was previously employed as a Chief Commercial Officer by Oyster Point Pharma, Inc., an Independent Director by Alimera Sciences, Inc., a Vice President & Head-Business Unit by Novartis Ophthalmics, Inc., a Group VP & Head-Ophthalmology Franchise by Novartis Pharmaceuticals Corp., a Group Vice President-Ophthalmology Business Unit by Takeda Pharmaceuticals U.S.A., Inc., a Vice President-Sales & Marketing by Genentech, Inc., a Vice President & General Manager-Ophthalmology by Novadaq Technologies, Inc., a Vice President by Novartis Pharmaceuticals Canada, Inc., and a VP-Sales & Marketing-Ophthalmics Unit by Ciba Vision Corp.
He also served on the board at The Foundation Fighting Blindness, Inc. He received his undergraduate degree from McGill University and an MBA from McGill University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ZENTEK LTD. 0,25 % | 27/05/2026 | 320 000 ( 0,25 % ) | 149 760 $ | 30/06/2026 |
| 10/06/2025 | 25 000 ( 0,04 % ) | 100 $ | 31/05/2026 |
Postes actifs de John Snisarenko
| Sociétés | Poste | Début |
|---|---|---|
| ZENTEK LTD. | Président | 25/09/2025 |
| CYTOPHAGE TECHNOLOGIES LTD. | Directeur/Membre du Conseil | 23/05/2024 |
Anciens postes connus de John Snisarenko
| Sociétés | Poste | Fin |
|---|---|---|
| ALIMERA SCIENCES, INC. | Directeur/Membre du Conseil | 16/09/2024 |
| OYSR POIN | Corporate Officer/Principal | 01/07/2022 |
Novartis Ophthalmics, Inc.
 Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, eye care and generic drugs | Corporate Officer/Principal | 01/09/2019 |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Corporate Officer/Principal | 01/09/2019 |
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01/06/2019 |
Formation de John Snisarenko
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
54
Relations au 1er degré
13
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 13 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Alimera Sciences, Inc.
 Alimera Sciences, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops, manufactures and commercializes therapeutics for ophthalmology, rheumatology, nephrology, neurology & pulmonology problems | Health Technology |
Novadaq Technologies, Inc.
 Novadaq Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures real-time fluorescence imaging products | Health Technology |
Zentek Ltd.
 Zentek Ltd. Other Metals/MineralsNon-Energy Minerals Engages in exploring mining projects and mineral deposits | Non-Energy Minerals |
Ciba Vision Corp.
 Ciba Vision Corp. Electronic ComponentsElectronic Technology Manufactures eyeglasses, contact lenses and lens care products | Electronic Technology |
McGill University
 McGill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Manufactures medicines and provides healthcare solutions | Health Technology |
The Foundation Fighting Blindness, Inc.
 The Foundation Fighting Blindness, Inc. Miscellaneous Commercial ServicesCommercial Services Provides preventions, treatments and cures for people affected by retinitis pigmentosa, macular degeneration and usher syndrome | Commercial Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Novartis Pharmaceuticals Canada, Inc.
 Novartis Pharmaceuticals Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Novartis Ophthalmics, Inc.
Novartis Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals, eye care and generic drugs | Health Technology |
Oyster Point Pharma, Inc.
 Oyster Point Pharma, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage biopharmaceutical company that develops and commercializes pharmaceutical therapies to treat ocular surface diseases | Commercial Services |
Cytophage Technologies Ltd.
 Cytophage Technologies Ltd. Financial ConglomeratesFinance Produces bacteriophages for bacterial infections and diseases | Finance |
Choisissez Zonebourse 
